Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study
- 31 March 2005
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 96 (3) , 749-752
- https://doi.org/10.1016/j.ygyno.2004.11.036
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerAnnals of Oncology, 2004
- Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1999
- Ifosfamide and Doxorubicin in the Treatment of Advanced Leiomyosarcomas of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenograftsCancer, 1994
- Resection of pulmonary metastases from uterine sarcomasGynecologic Oncology, 1992
- Phase II trial of ifosfamide and mesna in leiomyosarcoma ofthe uterus: A Gynecologic Oncology Group studyAmerican Journal of Obstetrics and Gynecology, 1992
- Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1991
- Cisplatin as Second-Line Chemotherapy in the Treatment of Advanced or Recurrent Leiomyosarcoma of the Uterus A Phase II Trial of the Gynecologic Oncology GroupAmerican Journal of Clinical Oncology, 1986
- Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicinVersus doxorubicin and cyclophosphamide (a phase III trial of the gynecologic oncology group)Cancer, 1985
- A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomasCancer, 1983